MedTrace Logo

Comparison of a "Step-Up" Versus a "Step-Down" Treatment Strategy for Patients With New Onset Dyspepsia in General Practice (The DIAMOND-Study)

NCT00247715 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 664

Last updated 2007-08-29

No results posted yet for this study

Summary

The purpose of this study was to determine which treatment strategy, the step-up or the step-down treatment strategy, is the most cost-effective treatment for patients with new onset dyspepsia in primary care.

Conditions

  • Dyspepsia
  • Gastrointestinal Diseases

Interventions

DRUG

algeldrate/magnesium oxide

DRUG

ranitidine

DRUG

pantoprazole

Sponsors & Collaborators

  • ZonMw: The Netherlands Organisation for Health Research and Development

    collaborator OTHER

  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • Jan BMJ Jansen, MD, PhD · Radboud University Nijmegen Medical Center

  • Robert JF Laheij, PhD · Radboud University Nijmegen Medical Center

  • Niek De Wit, MD, PhD · UMC Utrecht

  • Mattijs E Numans, MD, PhD · UMC Utrecht

  • Melvin Samsom, MD, PhD · UMC Utrecht

  • Jean WM Muris, MD, PhD · Maastricht University

  • Andre Knottnerus, MD, PhD · Maastricht University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-10-31
Completion
2007-01-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00247715 on ClinicalTrials.gov